{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:44:39Z","timestamp":1787921079356,"version":"build-2784847793"},"reference-count":121,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Candian Breast Cancer Foundation","award":["1029636"],"award-info":[{"award-number":["1029636"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The normal developmental program that prolactin generates in the mammary gland is usurped in the cancerous process and can be used out of its normal cellular context at a site of secondary metastasis. Prolactin is a pleiotropic peptide hormone and cytokine that is secreted from the pituitary gland, as well as from normal and cancerous breast cells. Experimental and epidemiologic data suggest that prolactin is associated with mammary gland development, and also the increased risk of breast tumors and metastatic disease in postmenopausal women. Breast cancer spreads to the bone in approximately 70% of cases with advanced breast cancer. Despite treatment, new bone metastases will still occur in 30%\u201350% of patients. Only 20% of patients with bone metastases survive five years after the diagnosis of bone metastasis. The breast cancer cells in the bone microenvironment release soluble factors that engage osteoclasts and\/or osteoblasts and result in bone breakdown. The breakdown of the bone matrix, in turn, enhances the proliferation of the cancer cells, creating a vicious cycle. Recently, it was shown that prolactin accelerated the breast cancer cell-mediated osteoclast differentiation and bone breakdown by the regulation of breast cancer-secreted proteins. Interestingly, prolactin has the potential to affect multiple proteins that are involved in both breast development and likely bone metastasis, as well. Prolactin has normal bone homeostatic roles and, combined with the natural \u201crecycling\u201d of proteins in different tissues that can be used for breast development and function, or in bone function, increases the impact of prolactin signaling in breast cancer bone metastases. Thus, this review will focus on the role of prolactin in breast development, bone homeostasis and in breast cancer to bone metastases, covering the molecular aspects of the vicious cycle.<\/jats:p>","DOI":"10.3390\/ijms17101764","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T10:46:39Z","timestamp":1477305999000},"page":"1764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["What Is Breast in the Bone?"],"prefix":"10.3390","volume":"17","author":[{"given":"Carrie","family":"Shemanko","sequence":"first","affiliation":[{"name":"Department of Biological Sciences and Arnie Charbonneau Cancer Institute, 2500 University Dr, NW, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Cong","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Arnie Charbonneau Cancer Institute, 2500 University Dr, NW, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Forsyth","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences and Arnie Charbonneau Cancer Institute, 2500 University Dr, NW, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"djv338","DOI":"10.1093\/jnci\/djv338","article-title":"The role of prolactin in bone metastasis and breast cancer cell-mediated osteoclast differentiation","volume":"108","author":"Sutherland","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/dbio.1999.9271","article-title":"Prolactin controls mammary gland development via direct and indirect mechanisms","volume":"210","author":"Brisken","year":"1999","journal-title":"Dev. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene","volume":"16","author":"Horseman","year":"1997","journal-title":"EMBO J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1101\/gad.11.2.167","article-title":"Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse","volume":"11","author":"Ormandy","year":"1997","journal-title":"Genes Dev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/mend.16.3.0805","article-title":"JAK2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium","volume":"16","author":"Shillingford","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/MCB.24.12.5510-5520.2004","article-title":"Impaired alveologenesis and maintenance of secretory mammary epithelial cells in JAK2 conditional knockout mice","volume":"24","author":"Wagner","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","article-title":"Inactivation of STAT5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation","volume":"24","author":"Cui","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1083\/jcb.200107065","article-title":"Signal transducer and activator of transcription (STAT) 5 controls the proliferation and differentiation of mammary alveolar epithelium","volume":"155","author":"Miyoshi","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1101\/gad.1840109","article-title":"Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5a","volume":"23","author":"Yamaji","year":"2009","journal-title":"Genes Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/sj.onc.1206619","article-title":"Prolactin induces eralpha-positive and eralpha-negative mammary cancer in transgenic mice","volume":"22","author":"Arendt","year":"2003","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1172\/JCI119820","article-title":"Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice","volume":"100","author":"Wennbo","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/annonc\/mdu150","article-title":"Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the epic cohort","volume":"25","author":"Tikk","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","article-title":"A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development","volume":"73","author":"Tworoger","year":"2013","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/bjc.1995.359","article-title":"The short-term and long-term effect of a pregnancy on breast cancer risk: A prospective study of 802,457 parous norwegian women","volume":"72","author":"Albrektsen","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1053\/ejso.2000.0943","article-title":"Prolactin as a local growth promoter in patients with breast cancer: Gcri experience","volume":"26","author":"Bhatavdekar","year":"2000","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1096-9098(199606)62:2<86::AID-JSO3>3.0.CO;2-M","article-title":"Node negative breast carcinoma: Hyperprolactinemia and\/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators","volume":"62","author":"Patel","year":"1996","journal-title":"J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0895-4356(94)00201-Z","article-title":"Serum prolactin levels and their relationship to survival in women with operable breast cancer","volume":"48","author":"Wang","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910340307","article-title":"Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer","volume":"34","author":"Holtkamp","year":"1984","journal-title":"Int. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/1097-0142(19900501)65:9<2028::AID-CNCR2820650924>3.0.CO;2-9","article-title":"Plasma prolactin as an indicator of disease progression in advanced breast cancer","volume":"65","author":"Bhatavdekar","year":"1990","journal-title":"Cancer"},{"key":"ref_20","first-page":"176","article-title":"Importance of serum prolactin determination in metastatic breast cancer patients","volume":"45","author":"Mujagic","year":"2004","journal-title":"Croat. Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/hmg\/11.8.863","article-title":"Gene expression profiles of poor-prognosis primary breast cancer correlate with survival","volume":"11","author":"Bertucci","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_22","first-page":"517","article-title":"Prognostic value of estrogen and prolactin receptor analysis in human breast cancer","volume":"76","author":"Waseda","year":"1985","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1038\/sj.onc.1210264","article-title":"Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells","volume":"26","author":"Miller","year":"2007","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/0008-5472.CAN-05-2292","article-title":"Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells","volume":"66","author":"Nouhi","year":"2006","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.onc.1208203","article-title":"STAT5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells","volume":"24","author":"Sultan","year":"2005","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1476-4598-12-59","article-title":"Global profiling of prolactin-modulated transcripts in breast cancer in vivo","volume":"12","author":"Sato","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/PAI.0000000000000178","article-title":"Prolactin receptor expression is an independent favorable prognostic marker in human breast cancer","volume":"24","author":"Hachim","year":"2016","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.humpath.2016.02.010","article-title":"A favorable role of prolactin in human breast cancer reveals novel pathway based gene signatures indicative of tumor differentiation and favorable patient outcome: Prolactin-induced mammary differentiation program in breast cancer prognosis","volume":"53","author":"Hachim","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/JME-16-0150","article-title":"Prolactin receptor in breast cancer: Marker for metastatic risk","volume":"57","author":"Shemanko","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Barcus, C.E., Holt, E.C., Keely, P.J., Eliceiri, K.W., and Schuler, L.A. (2015). Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116891"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1074\/jbc.M112.447631","article-title":"Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells","volume":"288","author":"Barcus","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"48093","DOI":"10.18632\/oncotarget.10137","article-title":"Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells","volume":"7","author":"Barcus","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","first-page":"2591","article-title":"Prolactin synthesis and secretion by human breast cancer cells","volume":"55","author":"Ginsburg","year":"1995","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/BD-2003-18108","article-title":"Role of prolactin\/prolactin receptor signaling in human breast cancer","volume":"18","author":"Clevenger","year":"2003","journal-title":"Breast Dis."},{"key":"ref_35","first-page":"451","article-title":"Convergence of signaling transduced by prolactin (PRL)\/cytokine chimeric receptors on PRL-responsive gene transcription","volume":"10","author":"Ferrag","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"ref_36","first-page":"197","article-title":"Immune function of prolactin (PRL) and signal transduction by PRL\/GH\/cytokine receptors: Specificity, redundancy and lessons from chimaeras","volume":"3","author":"Ferrag","year":"1997","journal-title":"Cytokines Cell. Mol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2009-1494","article-title":"Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas","volume":"95","author":"Courtillot","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chakhtoura, Z., Laki, F., Bernadet, M., Cherifi, I., Chiche, A., Pigat, N., Bernichtein, S., Courtillot, C., Boutillon, F., and Bieche, I. (2016). Gain-of-function prolactin receptor variants are not associated with breast cancer and multiple fibroadenoma risk. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/jc.2016-2372"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: Mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0080","article-title":"The science and practice of bone health in oncology: Managing bone loss and metastasis in patients with solid tumors","volume":"7","author":"Lipton","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.7.1.5163","article-title":"Biology of breast cancer bone metastasis","volume":"7","author":"Akhtari","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11154-006-9009-x","article-title":"Molecular regulation of osteoclast activity","volume":"7","author":"Bruzzaniti","year":"2006","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/jcp.20905","article-title":"CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients","volume":"210","author":"Lisignoli","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbrc.2008.11.083","article-title":"IGF2 modulates the microenvironment for osteoclastogenesis","volume":"378","author":"Nakao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the itam motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Takayanagi","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","article-title":"Mechanistic insight into osteoclast differentiation in osteoimmunology","volume":"83","author":"Takayanagi","year":"2005","journal-title":"J. Mol. Med."},{"key":"ref_51","first-page":"337","article-title":"Canonical and non-canonical pathways of osteoclast formation","volume":"24","author":"Knowles","year":"2009","journal-title":"Histol. Histopathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr1384","article-title":"Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]","volume":"8","author":"Powles","year":"2006","journal-title":"Breast Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1185\/03007995.2015.1105795","article-title":"A comprehensive review of denosumab for bone metastasis in patients with solid tumors","volume":"32","author":"Gul","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2012.06674.x","article-title":"The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction","volume":"1263","author":"Goessl","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2005.07.145","article-title":"Vascular endothelial growth factor receptors in osteoclast differentiation and function","volume":"335","author":"Aldridge","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1024443303436","article-title":"Tumor necrosis factor-\u03b1 induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells","volume":"80","author":"Harris","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"McCoy, E.M., Hong, H., Pruitt, H.C., and Feng, X. (2013). IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-16"},{"key":"ref_60","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites","volume":"51","author":"Powell","year":"1991","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jnci\/93.3.234","article-title":"Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases","volume":"93","author":"Henderson","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"Rank ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Jacob","year":"2010","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor rankl controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.bjc.6602417","article-title":"Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone","volume":"92","author":"Aldridge","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-5793(00)01520-9","article-title":"Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts","volume":"473","author":"Nakagawa","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjc.6690394","article-title":"Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma","volume":"80","author":"Fontanini","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02967443","article-title":"Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications","volume":"7","author":"Kurebayashi","year":"2000","journal-title":"Breast Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","article-title":"Role of cytokines in bone resorption","volume":"17","author":"Manolagas","year":"1995","journal-title":"Bone"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1152\/ajpendo.00666.2011","article-title":"Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals","volume":"302","author":"Hernandez","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"Adamts1 and mmp1 proteolytically engage egf-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"Lu","year":"2009","journal-title":"Genes Dev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","article-title":"Chemokine (C\u2013C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone","volume":"284","author":"Lu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.ajpath.2011.01.033","article-title":"CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone","volume":"178","author":"Ouellet","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","article-title":"Increased dickkopf-1 expression in breast cancer bone metastases","volume":"97","author":"Goehrig","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/jsre.2001.6204","article-title":"Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells","volume":"100","author":"Mancino","year":"2001","journal-title":"J. Surg. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-\u03baB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.1847","article-title":"Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis","volume":"28","author":"Logan","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-\u03baB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(01)00524-9","article-title":"Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases","volume":"169","author":"Sotiriou","year":"2001","journal-title":"Cancer Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived jagged1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells","volume":"19","author":"Sethi","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-008-0085-3","article-title":"Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model","volume":"116","author":"Eck","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10585-004-3503-x","article-title":"Breast cancer cells with inhibition of p38\u03b1 have decreased MMP-9 activity and exhibit decreased bone metastasis in mice","volume":"21","author":"Merrell","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1947601912458284","article-title":"Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation","volume":"3","author":"Bolin","year":"2012","journal-title":"Genes Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI114485","article-title":"Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo","volume":"85","author":"Garrett","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/1078-0432.306.11.1","article-title":"Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice","volume":"11","author":"Lev","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.canlet.2015.03.012","article-title":"Peroxiredoxin 4: A novel secreted mediator of cancer induced osteoclastogenesis","volume":"361","author":"Rafiei","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yang, Y.H., Buhamrah, A., Schneider, A., Lin, Y.L., Zhou, H., Bugshan, A., and Basile, J.R. (2016). Semaphorin 4d promotes skeletal metastasis in breast cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150151"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Das, S., Tucker, J.A., Khullar, S., Samant, R.S., and Shevde, L.A. (2012). Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034374"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1074\/jbc.M110.174920","article-title":"Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis","volume":"286","author":"Das","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1349-7006.2008.01012.x","article-title":"Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation","volume":"100","author":"Futakuchi","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccr.2011.11.002","article-title":"Vcam-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging \u03b14\u03b21-positive osteoclast progenitors","volume":"20","author":"Lu","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","article-title":"Molecular mechanisms of breast cancer metastases to bone","volume":"5","author":"Guise","year":"2005","journal-title":"Clin. Breast Cancer"},{"key":"ref_93","first-page":"917","article-title":"Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer","volume":"62","author":"Yi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00134.2010","article-title":"Bone modeling in bromocriptine-treated pregnant and lactating rats: Possible osteoregulatory role of prolactin in lactation","volume":"299","author":"Suntornsaratoon","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10911-005-5394-0","article-title":"Calcium and bone metabolism during pregnancy and lactation","volume":"10","author":"Kovacs","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ecl.2011.08.002","article-title":"Calcium and bone metabolism disorders during pregnancy and lactation","volume":"40","author":"Kovacs","year":"2011","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cellbi.2008.04.026","article-title":"Prolactin decreases the expression ratio of receptor activator of nuclear factor \u03baB ligand\/osteoprotegerin in human fetal osteoblast cells","volume":"32","author":"Seriwatanachai","year":"2008","journal-title":"Cell Biol. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jcb.22161","article-title":"Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization","volume":"107","author":"Seriwatanachai","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","article-title":"Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor \u03baB ligand\/osteoprotegerin ratio","volume":"42","author":"Seriwatanachai","year":"2008","journal-title":"Bone"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zaidi, M., Sun, L., Liu, P., Davies, T.F., New, M., Zallone, A., and Yuen, T. (2016). Pituitary-bone connection in skeletal regulation. Horm. Mol. Biol. Clin. Investig.","DOI":"10.1515\/hmbci-2016-0015"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-010-0674-4","article-title":"Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells","volume":"349","author":"Wongdee","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/endo.140.1.6436","article-title":"Osteoblasts are a new target for prolactin: Analysis of bone formation in prolactin receptor knockout mice","volume":"140","author":"Ormandy","year":"1999","journal-title":"Endocrinology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1139\/y00-040","article-title":"Changes in the regulation of calcium metabolism and bone calcium content during growth in the absence of endogenous prolactin and during hyperprolactinemia: A longitudinal study in male and female wistar rats","volume":"78","author":"Piyabhan","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygcen.2012.07.006","article-title":"Regulation of epithelial calcium transport by prolactin: From fish to mammals","volume":"181","author":"Wongdee","year":"2013","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tem.2010.02.002","article-title":"Is prolactin the cardinal calciotropic maternal hormone?","volume":"21","author":"Charoenphandhu","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/rp.58.1.297","article-title":"Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice","volume":"58","author":"Ormandy","year":"2003","journal-title":"Recent Prog. Horm. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"46171","DOI":"10.1074\/jbc.M308545200","article-title":"Receptor activator of NF-\u03baB ligand induction via JAK2 and STAT5a in mammary epithelial cells","volume":"278","author":"Srivastava","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1096\/fj.10-157982","article-title":"Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression","volume":"24","author":"Mukherjee","year":"2010","journal-title":"FASEB J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1242\/dev.088948","article-title":"Progesterone drives mammary secretory differentiation via RANKL-mediated induction of Elf5 in luminal progenitor cells","volume":"140","author":"Lee","year":"2013","journal-title":"Development"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/stem.2271","article-title":"RANKL impairs lactogenic differentiation through inhibition of the prolactin\/STAT5 pathway at midgestation","volume":"34","author":"Cordero","year":"2016","journal-title":"Stem Cells"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/mend-3-9-1443","article-title":"The mrna encoding a parathyroid hormone-like peptide is produced in mammary tissue in response to elevations in serum prolactin","volume":"3","author":"Thiede","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2005.01.005","article-title":"Prolactin-induced expression of vascular endothelial growth factor via egr-1","volume":"232","author":"Goldhar","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/107155769800500208","article-title":"Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells","volume":"5","author":"Sapi","year":"1998","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI200418776","article-title":"The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport","volume":"113","author":"VanHouten","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1096\/fj.07-8720com","article-title":"Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function","volume":"21","author":"Rossiter","year":"2007","journal-title":"FASEB J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020422900101","article-title":"The role of csf-1 in normal physiology of mammary gland and breast cancer: An update","volume":"229","author":"Sapi","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr3401","article-title":"The hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy","volume":"15","author":"Hui","year":"2013","journal-title":"Breast Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1634\/stemcells.2007-0691","article-title":"Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells","volume":"26","author":"Li","year":"2008","journal-title":"Stem Cells"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2010.04.016","article-title":"Activation of erk by sonic hedgehog independent of canonical hedgehog signalling","volume":"42","author":"Chang","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cub.2010.02.048","article-title":"Primary cilia regulate branching morphogenesis during mammary gland development","volume":"20","author":"McDermott","year":"2010","journal-title":"Curr. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/10\/1764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:33:43Z","timestamp":1760211223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/10\/1764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":121,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["ijms17101764"],"URL":"https:\/\/doi.org\/10.3390\/ijms17101764","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,22]]}}}